4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-004329
President and General Counsel sold 18,627 shares at an average $19.42 ($361,747)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2018-01-25 | Sale | −8,661 | $19.26 | $166,822 | 226,914 | D |
| Shandell Jason B. President and General Counsel | 2018-01-26 | Sale | −9,966 | $19.56 | $194,925 | 216,948 | D |
| Open-market sales · 18,627 sh · avg $19.42 · $361,747 | |||||||
Loading xslF345X03/a4.xml…